Rob Bresnahan sold REGN (Regeneron Pharmaceuticals Inc) on Feb 25, 2025 with an estimated value between $1,000 and $15,000. This trade was filed under undisclosed. The stock is currently up 5.3% from the trade price.

Rob Bresnahan

Republican· house

Pennsylvania

REGN

Regeneron Pharmaceuticals Inc

Health Care

Trade Details

Transaction

Sale

Trade Date

Feb 25, 2025(1 year ago)

Disclosed

Mar 28, 202531d gap

Owner

undisclosed

Estimated Value

$1,000 – $15,000

Trade Price

$723.47

Price Today

$761.85

Return (if held)

+5.3%

Rob Bresnahan sold $REGN at $723.47 on Feb 25, 2025

View all 3 trades on REGN

Price Change Since Trade

+5.3%